Which Is the Better Healthcare ETF: First Trust's High-Conviction FBT or Vanguard's Low-Cost VHT?

This comparative analysis examines two healthcare-focused ETFs with divergent investment philosophies. FBT (First Trust High-Conviction) has delivered impressive 51.6% annual returns, reflecting concentrated exposure to high-conviction healthcare holdings that likely benefited from sector momentum and selective stock appreciation. However, this performance comes paired with elevated volatility and expense ratios, creating a risk-return trade-off that favors aggressive allocators.

VHT (Vanguard Health Care ETF) represents the opposite end of the spectrum—broader market-cap weighted diversification with minimal cost friction. The expense ratio differential compounds meaningfully over multi-decade holding periods, with Vanguard's structural cost advantage translating to meaningful long-term alpha retention. The lower volatility profile appeals to conservative allocators seeking healthcare sector exposure without concentration risk.

The article implicitly highlights a structural decision facing healthcare investors: tactical conviction bets versus strategic market participation. FBT's outperformance reflects successful stock selection in a favorable Health Care environment, but reversion-to-mean dynamics and fee drag pose headwinds. VHT's mediocre recent returns mask the compounding benefit of cost efficiency and reduced idiosyncratic risk exposure across a 50+ holding portfolio.

Sector implication: Health Care's defensive characteristics and demographic tailwinds continue attracting capital, but the performance divergence between active/concentrated strategies (FBT) and passive/diversified structures (VHT) reflects ongoing pressure on active management fees and the persistent challenge of beating broad indices after costs.